Selected Publication:
Holzer, P; Holzer-Petsche, U.
Tachykinin receptors in the gut: physiological and pathological implications.
Curr Opin Pharmacol. 2001; 1(6): 583-590.
Doi: 10.1016/S1471-4892(01)00100-X
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
-
Holzer Peter
- Co-authors Med Uni Graz
-
Holzer Ulrike
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The tachykinins substance P and neurokinin A participate in the regulation of gastrointestinal motility, secretion, vascular permeability and pain sensitivity. Advances made during the past two years corroborate a causal involvement of tachykinins in inflammation-induced disturbances of gut function, such as dysmotility, secretory diarrhoea, oedema and hyperalgesia. It would therefore appear that tachykinin receptors, which in the digestive system are expressed in a cell-specific manner, represent attractive targets for novel therapeutics in gastroenterology.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Colonic Diseases, Functional - drug therapy
-
Digestive Physiology - drug therapy
-
Digestive System - metabolism
-
Gastrointestinal Diseases - drug therapy
-
Gastrointestinal Motility - drug therapy
-
Humans - drug therapy
-
Inflammatory Bowel Diseases - drug therapy
-
Neurokinin A - metabolism
-
Receptors, Neurokinin-1 - metabolism
-
Receptors, Neurokinin-2 - metabolism
-
Receptors, Neurokinin-3 - metabolism
-
Receptors, Tachykinin - antagonists and inhibitors
-
Research Support, Non-U.S. Gov't - antagonists and inhibitors
-
Substance P - metabolism